Max Healthcare Institute (MAXHEALTH) — Annual Report

Max Healthcare Institute Limited reported a 26% YoY revenue increase to H9,065 Crore and 21.6% EBITDA growth to H2,319 Crore for FY2024-25, driven by hospital network expansion, digital transformation, and technology adoption. The company proposed a final dividend of ₹1.50 per share (15% of face value) and outlined plans to double bed capacity within five years while investing in AI, robotic surgery, and oncology. ESG initiatives include renewable energy adoption (56,234 GJ), water conservation, and waste management, with no material climate-related financial risks identified. Governance practices emphasize board independence, ESG committee oversight, and compliance with SEBI regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this annual report affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 4 July 2025?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 4 July 2025

BAJFINANCE Bajaj Finance Limited Financial Results TECHM Tech Mahindra Limited Financial Results TECHM Tech Mahindra Limited Financial Results SUNPHARMA Sun Pharmaceutical Industries Limited Annual Report ULTRACEMCO UltraTech Cement Limited Announcement GODREJCP Godrej Consumer Products Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.